News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
185,809 Results
Type
Article (8985)
Company Profile (40)
Press Release (176784)
Section
Business (57452)
Career Advice (395)
Deals (7291)
Drug Delivery (19)
Drug Development (21774)
Employer Resources (48)
FDA (3522)
Job Trends (4444)
News (89701)
Policy (6066)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Genetown Standard (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (997)
Accelerated approval (1)
Adcomms (3)
Allergies (23)
Alliances (16202)
ALS (27)
Alzheimer's disease (565)
Antibody-drug conjugate (ADC) (21)
Approvals (3518)
Artificial intelligence (108)
Autoimmune disease (4)
Automation (7)
Bankruptcy (38)
Best Places to Work (3924)
BIOSECURE Act (1)
Biosimilars (18)
Biotechnology (26)
Bladder cancer (20)
Brain cancer (8)
Breast cancer (91)
Cancer (617)
Cardiovascular disease (75)
Career advice (345)
Career pathing (9)
CAR-T (40)
Cell therapy (107)
Cervical cancer (2)
Clinical research (16964)
Collaboration (274)
Compensation (41)
Complete response letters (3)
COVID-19 (761)
CRISPR (19)
C-suite (91)
Cystic fibrosis (36)
Data (760)
Denatured (1)
Depression (11)
Diabetes (64)
Diagnostics (2226)
Digital health (7)
Diversity, equity & inclusion (11)
Drug discovery (40)
Drug pricing (10)
Drug shortages (3)
Duchenne muscular dystrophy (31)
Earnings (17777)
Editorial (7)
Employer branding (7)
Employer resources (43)
Events (28825)
Executive appointments (244)
FDA (3818)
Featured Employer (15)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (244)
Gene editing (39)
Generative AI (11)
Gene therapy (88)
GLP-1 (178)
Government (992)
Guidances (15)
Healthcare (5057)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (22)
Indications (9)
Infectious disease (797)
Inflammatory bowel disease (47)
Influenza (12)
Intellectual property (21)
Interviews (59)
IPO (2922)
IRA (5)
Job creations (728)
Job search strategy (298)
Kidney cancer (2)
Labor market (7)
Layoffs (92)
Leadership (5)
Legal (1024)
Liver cancer (14)
Lung cancer (80)
Lymphoma (38)
Machine learning (2)
Management (17)
Manufacturing (57)
MASH (22)
Medical device (3191)
Medtech (3195)
Mergers & acquisitions (4502)
Metabolic disorders (169)
Multiple sclerosis (21)
NASH (5)
Neurodegenerative disease (27)
Neuropsychiatric disorders (7)
Neuroscience (727)
NextGen: Class of 2025 (1863)
Non-profit (1499)
Northern California (696)
Now hiring (6)
Obesity (84)
Opinion (55)
Ovarian cancer (12)
Pain (16)
Pancreatic cancer (18)
Parkinson's disease (54)
Partnered (5)
Patents (42)
Patient recruitment (27)
Peanut (9)
People (20396)
Pharmaceutical (8)
Phase I (5053)
Phase II (7175)
Phase III (5951)
Pipeline (330)
Podcasts (3)
Policy (22)
Postmarket research (674)
Preclinical (3253)
Press Release (34)
Prostate cancer (27)
Psychedelics (11)
Radiopharmaceuticals (56)
Rare diseases (105)
Real estate (1444)
Recruiting (20)
Regulatory (4554)
Reports (10)
Research institute (1135)
Resumes & cover letters (73)
Rett syndrome (1)
RNA editing (1)
RSV (5)
Schizophrenia (17)
Series A (61)
Series B (18)
Sickle cell disease (25)
Southern California (566)
Special edition (1)
Spinal muscular atrophy (67)
Sponsored (14)
Startups (1360)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (1)
The Weekly (2)
United States (6128)
Vaccines (136)
Venture capitalists (9)
Webinars (3)
Weight loss (36)
Women's health (8)
Worklife (2)
Date
Today (31)
Last 7 days (152)
Last 30 days (809)
Last 365 days (9614)
2025 (2359)
2024 (10230)
2023 (11909)
2022 (15879)
2021 (17105)
2020 (15901)
2019 (13845)
2018 (10439)
2017 (9880)
2016 (9578)
2015 (10358)
2014 (7616)
2013 (6141)
2012 (6647)
2011 (7008)
2010 (5893)
Location
Africa (212)
Alabama (13)
Alaska (4)
Arizona (44)
Arkansas (2)
Asia (9588)
Australia (1557)
California (1535)
Canada (543)
China (100)
Colorado (71)
Connecticut (76)
Delaware (35)
Europe (26937)
Florida (184)
Georgia (49)
Idaho (12)
Illinois (117)
India (3)
Indiana (59)
Iowa (1)
Japan (36)
Kansas (14)
Kentucky (4)
Louisiana (3)
Maine (62)
Maryland (203)
Massachusetts (1317)
Michigan (78)
Minnesota (82)
Mississippi (2)
Missouri (23)
Montana (5)
Nebraska (7)
Nevada (13)
New Hampshire (24)
New Jersey (397)
New Mexico (23)
New York (558)
North Carolina (242)
North Dakota (2)
Northern California (696)
Ohio (81)
Oklahoma (7)
Oregon (22)
Pennsylvania (337)
Puerto Rico (2)
Rhode Island (13)
South America (255)
South Carolina (5)
Southern California (566)
Tennessee (20)
Texas (255)
Utah (77)
Virginia (34)
Washington D.C. (12)
Washington State (159)
Wisconsin (15)
185,809 Results for "openeye scientific software".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cadence Completes Acquisition of OpenEye Scientific
Cadence Design Systems, Inc. (Nasdaq: CDNS) announced today that it has completed the acquisition of OpenEye Scientific Software, Inc. (“OpenEye”).
September 1, 2022
·
4 min read
Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific
Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye Scientific’s cheminformatics toolkits.
July 22, 2021
·
3 min read
Press Releases
Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software
April 2, 2025
·
3 min read
Genetown
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
Boston Scientific Corporation has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track the FARAWAVE™ Nav Pulsed Field Ablation Catheter* for the treatment of patients with paroxysmal and persistent atrial fibrillation.
April 8, 2024
·
5 min read
Press Releases
Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery
April 2, 2025
·
2 min read
Business
OpenEye Scientific Introduces Its Scientific Advisory Board
OpenEye Scientific, an industry leader in computational molecular design, has officially introduced its Scientific Advisory Board, which includes experts in the fields of biophysics and molecular modeling.
October 28, 2021
·
3 min read
Press Releases
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
February 26, 2025
·
8 min read
Business
OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™
OpenEye Scientific and Specifica, Inc., announced they are releasing jointly developed software to help antibody engineers and bioinformaticians at pharmaceutical and biotechnology companies advance antibody discovery by identifying diverse antibody sets with better properties for downstream therapeutics development.
December 2, 2021
·
4 min read
Biotech Beach
Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows
Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.
January 17, 2024
·
3 min read
Press Releases
eyonis™ LCS, Median Technologies’ AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study
March 31, 2025
·
8 min read
1 of 18,581
Next
